Synthetic cannabinoid withdrawal (Q40341): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Abstinência de canabinoides sintéticos é um conjunto clinicamente significativo de sintomas, comportamentos e/ou características fisiológicas, variando em grau de gravidade e duração, que ocorre quando da cessação ou redução do uso de canabinoides sintéticos em indivíduos que tenham desenvolvido dependência de canabinoides sintéticos ou tenham usado canabinoides sintéticos por um período prolongado ou em grandes quantidades. Sintomas de apresentação da abstinência de canabinoides sintéticos podem incluir irritabilidade, raiva, agressão, tremor, insônia e sonhos perturbadores, inquietação, ansiedade, humor deprimido e alteração de apetite. Na fase inicial, a abstinência de canabinoides sintéticos pode ser acompanhada por manifestações residuais de intoxicação pela droga, como ideação paranoide e alucinações auditivas e visuais. | |||
| description / en | description / en | ||
Synthetic cannabinoid withdrawal is a clinically significant cluster of symptoms, behaviours and/or physiological features, varying in degree of severity and duration, that occurs upon cessation or reduction of use of synthetic cannabinoids in individuals who have developed Synthetic cannabinoid dependence or have used synthetic cannabinoids for a prolonged period or in large amounts. Presenting features of Synthetic cannabinoid withdrawal may include irritability, anger, aggression, shakiness, insomnia and disturbing dreams, restlessness, anxiety, depressed mood and appetite disturbance. In the early phase, Synthetic cannabinoid withdrawal may be accompanied by residual features of intoxication from the drug, such as paranoid ideation and auditory and visual hallucinations. | |||
Revision as of 06:06, 13 August 2026
Synthetic cannabinoid withdrawal is a clinically significant cluster of symptoms, behaviours and/or physiological features, varying in degree of severity and duration, that occurs upon cessation or reduction of use of synthetic cannabinoids in individuals who have developed Synthetic cannabinoid dependence or have used synthetic cannabinoids for a prolonged period or in large amounts. Presenting features of Synthetic cannabinoid withdrawal may include irritability, anger, aggression, shakiness, insomnia and disturbing dreams, restlessness, anxiety, depressed mood and appetite disturbance. In the early phase, Synthetic cannabinoid withdrawal may be accompanied by residual features of intoxication from the drug, such as paranoid ideation and auditory and visual hallucinations.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 6C42.4 |
||
| English | Synthetic cannabinoid withdrawal |
Synthetic cannabinoid withdrawal is a clinically significant cluster of symptoms, behaviours and/or physiological features, varying in degree of severity and duration, that occurs upon cessation or reduction of use of synthetic cannabinoids in individuals who have developed Synthetic cannabinoid dependence or have used synthetic cannabinoids for a prolonged period or in large amounts. Presenting features of Synthetic cannabinoid withdrawal may include irritability, anger, aggression, shakiness, insomnia and disturbing dreams, restlessness, anxiety, depressed mood and appetite disturbance. In the early phase, Synthetic cannabinoid withdrawal may be accompanied by residual features of intoxication from the drug, such as paranoid ideation and auditory and visual hallucinations. |
